These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6173031)

  • 1. [Anoxic cardiac arrest - 3 hours' protection - new cardioplegic solution].
    Gomes OM; Barros-Moraes NL; Fiorelli AI; Brum JM; Ribeiro MP; Calonge Hde C; Armelin E; Bittencourt D; Zerbini EJ
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():8-12. PubMed ID: 6173031
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium-induced ventricular contraction during cardioplegic arrest.
    Torchiana DF; Love TR; Hendren WG; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):606-13. PubMed ID: 3657262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of immature myocardium by the addition of mannitol to crystalloid cardioplegic solution.
    Yang YJ
    J Formos Med Assoc; 1991 Jan; 90(1):24-30. PubMed ID: 1679105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of crystalloid and sanguineous cardioplegic solutions in the dog.
    Spackman CJ; Caywood DD; Gannon PG; Irmiter RA; Louis CF
    Am J Vet Res; 1985 Jun; 46(6):1330-4. PubMed ID: 4026010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial anoxia lasting 3 hours. Comparative study of cardioplegic solutions].
    Gomes OM; Dallan LA; Salles DD; Ledoux DS; Fu WS; Fiorelli AI; Brum JM; Ribeiro MP; Armelin E; Verginelli G; Bittencourt D; Zerbini EJ
    Arq Bras Cardiol; 1980 Oct; 35(4):269-72. PubMed ID: 6260068
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial protection during prolonged ischaemic cardiac arrest: experimental evaluation of three crystalloid cardioplegic solutions.
    Chong YS; Cottier DS; Gavin JB
    J Cardiovasc Surg (Torino); 1994 Feb; 35(1):35-44. PubMed ID: 8120076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myocardial protection during ischemic cardiac arrest. Hemodynamic study of the effects of allopurinol in a cardioplegic solution].
    Périer P; Fabiani JN; Bocher M; Massoud H; Carpentier A; Dubost C
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):713-8. PubMed ID: 6779765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic myocardial edema with potassium cardioplegia.
    Foglia RP; Steed DL; Follette DM; DeLand E; Buckberg GD
    J Thorac Cardiovasc Surg; 1979 Aug; 78(2):217-22. PubMed ID: 459529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygenation of cardioplegic solutions. Potential for the calcium paradox.
    Hendren WG; Geffin GA; Love TR; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
    J Thorac Cardiovasc Surg; 1987 Oct; 94(4):614-25. PubMed ID: 3116349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioplegic solutions.
    Kolata RJ
    Am J Vet Res; 1986 Jan; 47(1):197-8. PubMed ID: 3946903
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection of the immature myocardium during ischemic arrest: dose dependent effects of glucose and mannitol when added to St Thomas' cardioplegic solution.
    Yang SS; Hearse DJ
    Can J Cardiol; 1989; 5(8):401-7. PubMed ID: 2514036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the pH of cardioplegic solution on postarrest myocardial preservation.
    Nugent WC; Levine FH; Liapis CD; LaRaia PJ; Tsai CH; Buckley MJ
    Circulation; 1982 Aug; 66(2 Pt 2):I68-72. PubMed ID: 7083549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of potassium-based cardioplegic solutions and pharmacologic agents on normothermic ischemic myocardium (author's transl)].
    Shida H
    Nihon Kyobu Geka Gakkai Zasshi; 1980 Jul; 28(7):1115-22. PubMed ID: 7462740
    [No Abstract]   [Full Text] [Related]  

  • 15. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
    Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
    J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of multidose cardioplegia and cardioplegic solution buffering on myocardial tissue acidosis.
    Tait GA; Booker PD; Wilson GJ; Coles JG; Steward DJ; MacGregor DC
    J Thorac Cardiovasc Surg; 1982 Jun; 83(6):824-9. PubMed ID: 6283276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial respiration and edema following hypothermic cardioplegia and anoxic arrest.
    Sunamori M; Harrison CE
    J Thorac Cardiovasc Surg; 1979 Aug; 78(2):208-16. PubMed ID: 459528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts.
    Myers CL; Weiss SJ; Kirsh MM; Shepard BM; Shlafer M
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):281-9. PubMed ID: 3945095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of protective effects of carnosine and acetylcarnosine during cardioplegia].
    Alabovskiĭ VV; Boldyrev AA; Vinokurov AA; Gallant S; Chesnokov DN
    Biull Eksp Biol Med; 1999 Mar; 127(3):290-4. PubMed ID: 10225102
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phosphocreatine in the protection of the myocardium in cardioplegic arrest; biochemical and functional aspects in the dog].
    Bricco G; Piacenza G; Borgoglio R; Zamperone O; Sguazzi P
    Cardiologia; 1986 Jul; 31(7):509-14. PubMed ID: 3568043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.